Castle Biosciences Inc (CSTL)

Jan 03, 2025

Castle Biosciences (NASDAQ:CSTL) Given Overweight Rating at Stephens - Defense World

Jan 03, 2025

Jan 02, 2025

Castle Biosciences (NASDAQ:CSTL) Earns Overweight Rating from Stephens - MarketBeat

Jan 02, 2025

Jan 02, 2025

Beyond The Numbers: 7 Analysts Discuss Castle Biosciences Stock - Benzinga

Jan 02, 2025

Dec 31, 2024

Brokerages Set Castle Biosciences, Inc. (NASDAQ:CSTL) PT at $39.71 - Defense World

Dec 31, 2024

Dec 29, 2024

Barclays PLC Raises Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - MarketBeat

Dec 29, 2024

Dec 29, 2024

Geode Capital Management LLC Increases Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Dec 29, 2024

Dec 29, 2024

Barclays PLC Has $1.49 Million Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Dec 29, 2024

Dec 28, 2024

Analysts Set Castle Biosciences, Inc. (NASDAQ:CSTL) PT at $39.71 - MarketBeat

Dec 28, 2024

Dec 27, 2024

Castle Biosciences, Inc. (NASDAQ:CSTL) Stock Holdings Lifted by Franklin Resources Inc. - MarketBeat

Dec 27, 2024

Dec 24, 2024

Castle Biosciences reports preliminary data from atopic dermatitis test study - Yahoo! Voices

Dec 24, 2024

Dec 24, 2024

State Street Corp Acquires 60,924 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Dec 24, 2024

Dec 24, 2024

Castle Biosciences to launch AD test by end of 2025 - Investing.com Canada

Dec 24, 2024

Dec 23, 2024

Castle Biosciences Unveils Promising Early Data for Revolutionary Atopic Dermatitis Test - StockTitan

Dec 23, 2024

Dec 23, 2024

Principal Financial Group Inc. Buys 40,377 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - MarketBeat

Dec 23, 2024

Dec 19, 2024

Castle Biosciences CEO Derek Maetzold sells $265,357 in shares - Investing.com India

Dec 19, 2024

Dec 19, 2024

Insider Selling: Castle Biosciences, Inc. (NASDAQ:CSTL) Insider Sells 9,364 Shares of Stock - MarketBeat

Dec 19, 2024

Dec 19, 2024

Castle Biosciences CEO Derek Maetzold sells $265,357 in shares By Investing.com - Investing.com South Africa

Dec 19, 2024

Dec 19, 2024

The True Test of Success - BOSS Magazine

Dec 19, 2024

Dec 19, 2024

Castle Biosciences Awards Major RSU Package to 135 Employees in Strategic Retention Move - StockTitan

Dec 19, 2024

Dec 18, 2024

Wall Street Analysts Believe Castle Biosciences (CSTL) Could Rally 42.02%: Here's is How to Trade - MSN

Dec 18, 2024

Dec 17, 2024

Castle Biosciences CEO Derek Maetzold sells $750,296 in stock - Investing.com India

Dec 17, 2024

Dec 17, 2024

Short Interest in Castle Biosciences, Inc. (NASDAQ:CSTL) Expands By 7.6% - MarketBeat

Dec 17, 2024

Dec 16, 2024

Captrust Financial Advisors Decreases Stake in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Dec 16, 2024

Dec 14, 2024

Castle Biosciences (CSTL) Is a Great Choice for 'Trend' Investors, Here's Why - MSN

Dec 14, 2024

Dec 12, 2024

Independent Systematic Review and Meta-Analysis Attests to the Significant Risk Stratification Provided by Castle Biosciences’ DecisionDx®-Melanoma Test, Contributing to Personalized Management of Patients with Melanoma - Business Wire

Dec 12, 2024

Dec 11, 2024

Charles Schwab Investment Management Inc. Boosts Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - MarketBeat

Dec 11, 2024

Dec 09, 2024

Castle Biosciences CEO Derek Maetzold sells $160,741 in shares - Investing.com India

Dec 09, 2024

Dec 09, 2024

Castle Biosciences CEO Derek Maetzold sells $160,741 in shares By Investing.com - Investing.com UK

Dec 09, 2024

Dec 07, 2024

Point72 Asset Management L.P. Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - MarketBeat

Dec 07, 2024

Dec 06, 2024

Castle Biosciences director Daniel Bradbury sells $243,692 in stock By Investing.com - Investing.com Canada

Dec 06, 2024

Dec 05, 2024

Castle Biosciences director Daniel Bradbury sells $243,692 in stock - Investing.com India

Dec 05, 2024

Dec 05, 2024

Jacobs Levy Equity Management Inc. Has $14.16 Million Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - MarketBeat

Dec 05, 2024

Dec 04, 2024

Castle Biosciences Inc (CSTL) Trading 3% Higher on Dec 4 - GuruFocus.com

Dec 04, 2024

Dec 04, 2024

Parkman Healthcare Partners LLC Purchases 18,176 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - MarketBeat

Dec 04, 2024

Dec 03, 2024

Castle Biosciences, Inc. (NASDAQ:CSTL) Receives $37.88 Consensus Target Price from Analysts - MarketBeat

Dec 03, 2024

Dec 02, 2024

Castle Biosciences Inc (CSTL) Stock Price Down 3.73% on Dec 2 - GuruFocus.com

Dec 02, 2024

Dec 01, 2024

Bellevue Group AG Buys 44,929 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - MarketBeat

Dec 01, 2024

Nov 30, 2024

Braidwell LP Sells 84,114 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - MarketBeat

Nov 30, 2024

Nov 27, 2024

43,894 Shares in Castle Biosciences, Inc. (NASDAQ:CSTL) Bought by Dynamic Technology Lab Private Ltd - MarketBeat

Nov 27, 2024

Nov 25, 2024

Are Medical Stocks Lagging AnaptysBio (ANAB) This Year? - Yahoo Finance

Nov 25, 2024

Nov 24, 2024

Connor Clark & Lunn Investment Management Ltd. Grows Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - MarketBeat

Nov 24, 2024

Nov 22, 2024

Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.

Nov 22, 2024

Nov 20, 2024

Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference - BioSpace

Nov 20, 2024

Nov 20, 2024

Castle Biosciences to Present at Piper Sandler Healthcare Conference in December | CSTL Stock News - StockTitan

Nov 20, 2024

Nov 20, 2024

Castle Biosciences (CSTL) Upgraded to Strong Buy: Here's Why - MSN

Nov 20, 2024

Nov 19, 2024

Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year - Business Wire

Nov 19, 2024